PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8119464

Haematocervix during hormonal replacement therapy.

F Pansini·C Campobasso·G Bonaccorsi·M Calisesi·D D Defazio·G Perri·G Mollica
View original source ↗Export metadata ↓

Abstract

A postmenopausal woman, receiving cyclic hormonal therapy, presented to our clinic with acute pelvic pain, absence of withdrawal bleeding and clinical signs of vagal stimulation (nausea and vomiting). Vaginal exploration and ultrasonographic imaging accounted for haematocervix, which was confirmed by surgical blood evacuation.

Explore related subjects

Estrogen Replacement TherapyFemaleHematometraHumansMiddle AgedUltrasonographyCase ReportsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F Pansini, C Campobasso, G Bonaccorsi, M Calisesi, D D Defazio, G Perri, G Mollica. 1993. Haematocervix during hormonal replacement therapy.. https://doi.org/10.1016/0028-2243(93)90030-g

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Clinical guidelines for improving compliance with hormone therapy in Latin American women during the menopausal transition and thereafter.

OBJECTIVE: To provide uniform, objective guidance for physicians and other health care workers in Latin America to enhance compliance with hormone therapy (HT), and to provide a tool for continued medical education and a source for answering clinical questions. METHOD: Literature search using MEDLINE; identification of key relevant publications by a five-member expert committee; creation and validation of a 60-item questionnaire used to survey the opinion of 72 physicians participating in a Latin American symposium, "The Faces of Menopause". RESULTS: On the basis of the validated responses, major points were identified to enhance compliance with HT with specific reference to Latin America, and two algorithms were created to provide practical guidance. CONCLUSION: The present guidelines will facilitate optimal compliance with therapy in Latin American postmenopausal women who opt for HT and for whom HT is indicated.

Estrogen Replacement Therapy↗